Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical compound for curing prostatitis and prostate hyperplasia and preparation method and preparation thereof

A technology for prostatic hyperplasia and prostatitis, which is applied in the directions of drug combinations, pharmaceutical formulations, and medical preparations containing active ingredients, etc. Infiltration and inflammatory edema, anti-inflammatory effect, good therapeutic effect

Active Publication Date: 2009-12-09
ZHEJIANG JOLLY PHARMA
View PDF3 Cites 18 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] In order to solve the technical defects of relatively large side effects of existing western medicines, complex formulas of traditional Chinese medicine preparations and complicated production processes

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical compound for curing prostatitis and prostate hyperplasia and preparation method and preparation thereof
  • Pharmaceutical compound for curing prostatitis and prostate hyperplasia and preparation method and preparation thereof
  • Pharmaceutical compound for curing prostatitis and prostate hyperplasia and preparation method and preparation thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0027] A pharmaceutical composition for treating prostatitis and benign prostatic hyperplasia, the pharmaceutical composition is prepared from Chinese medicinal raw materials comprising the following proportions by weight:

[0028] 80 parts of Wuling powder, 50 parts of curcuma

[0029] 30 parts of Fritillaria and 25 parts of Alisma.

[0030] The preparation method is as follows: the powder of Wuling bacteria is crushed into fine powder, and set aside; the volatile oil is extracted from the zedoary, and the dregs are combined with Fritillaria and Alisma, extracted three times, each time for 2 hours, combined extracts, filtered, concentrated under reduced pressure to relative Density 1.05~1.15kg / m 3 (measured at 60°C), add ethanol to make the alcohol content reach 50% to 70%, let it stand overnight, filter, concentrate the filtrate under reduced pressure, and dry; the volatile oil is clathrated with β-cyclodextrin; The bleeding bacteria powder, the dry paste powder of medicin...

Embodiment 2

[0032] A pharmaceutical composition for treating prostatitis and benign prostatic hyperplasia, the pharmaceutical composition is prepared from Chinese medicinal raw materials comprising the following proportions by weight:

[0033] 65 parts of Wuling powder, 35 parts of curcuma

[0034] 60 parts of Fritillaria and 35 parts of Alisma.

[0035] The preparation method is as described in Example 1.

Embodiment 3

[0037] A pharmaceutical composition for treating prostatitis and benign prostatic hyperplasia, the pharmaceutical composition is prepared from Chinese medicinal raw materials comprising the following proportions by weight:

[0038] 95 parts of Wuling powder, 75 parts of curcuma

[0039] 60 parts of Fritillaria and 40 parts of Alisma.

[0040] The preparation method is as described in Example 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a pharmaceutical compound and a preparation method and a preparation thereof, in particular to a pharmaceutical compound for curing prostatitis and prostate hyperplasia and a preparation method and a preparation thereof. The pharmaceutical compound is prepared by the following traditional Chinese medicine raw materials according to the parts by weight: 60-100 parts of wuling powder, 20-80 parts of zedoary, 20-80 parts of fritillaria thunbergii and 20-40 parts of alisma orientale. The invention also discloses the preparation method and the preparation of the pharmaceutical compound. The pharmaceutical compound and the preparation thereof have good curative effects to prostatitis and prostate hyperplasia without side effects.

Description

technical field [0001] The invention relates to a pharmaceutical composition and its preparation method and preparation, in particular to a pharmaceutical composition for treating prostatitis and benign prostatic hyperplasia, its preparation method and preparation. Background technique [0002] Prostate disease is one of the common diseases in elderly men. If it is not treated in time, the disease will easily aggravate and seriously affect the normal work and life of the patient. At present, the existing treatment methods include oral drug therapy and surgical treatment. Because surgical treatment is very easy to cause physical and mental pain to patients, oral drug therapy is the first choice for patients at present. And oral western medicine, though instant effect, side effect is bigger, takes for a long time, easily causes viscera damages such as liver, kidney, and price is higher in addition, increases the economic burden of the patient. Also have some to utilize tradit...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/9066A61P13/08
Inventor 陈建罗艳萍董调雅邹永胜朱方剑林丽萍姚瑶陈文祥李福
Owner ZHEJIANG JOLLY PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products